SI1115704T1 - Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes - Google Patents
Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexesInfo
- Publication number
- SI1115704T1 SI1115704T1 SI9930391T SI9930391T SI1115704T1 SI 1115704 T1 SI1115704 T1 SI 1115704T1 SI 9930391 T SI9930391 T SI 9930391T SI 9930391 T SI9930391 T SI 9930391T SI 1115704 T1 SI1115704 T1 SI 1115704T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cyclin
- inhibitory effect
- various kinases
- novel substituted
- substituted indolinones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19844003A DE19844003A1 (de) | 1998-09-25 | 1998-09-25 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE19937496A DE19937496A1 (de) | 1999-08-07 | 1999-08-07 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1999/007040 WO2000018734A1 (de) | 1998-09-25 | 1999-09-22 | Neue substituierte indolinone mit inhibierender wirkung auf verschiedene kinasen und cyclin/cdk-komplexe |
| EP99947404A EP1115704B1 (de) | 1998-09-25 | 1999-09-22 | Neue substituierte indolinone mit einer inhibierenden wirkung auf verschiedene kinasen und cyclin/cdk-komplexe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1115704T1 true SI1115704T1 (en) | 2003-12-31 |
Family
ID=26049076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9930391T SI1115704T1 (en) | 1998-09-25 | 1999-09-22 | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6855710B2 (sh) |
| EP (1) | EP1115704B1 (sh) |
| JP (1) | JP2002525356A (sh) |
| KR (1) | KR20010085841A (sh) |
| CN (1) | CN1319090A (sh) |
| AT (1) | ATE243195T1 (sh) |
| AU (1) | AU763361B2 (sh) |
| BG (1) | BG105327A (sh) |
| BR (1) | BR9914065A (sh) |
| CA (1) | CA2342622A1 (sh) |
| DE (1) | DE59906030D1 (sh) |
| DK (1) | DK1115704T3 (sh) |
| EA (1) | EA200100320A1 (sh) |
| EE (1) | EE200100184A (sh) |
| ES (1) | ES2196860T3 (sh) |
| HR (1) | HRP20010216A2 (sh) |
| HU (1) | HUP0104973A3 (sh) |
| ID (1) | ID27757A (sh) |
| IL (1) | IL141622A0 (sh) |
| NO (1) | NO20011477D0 (sh) |
| NZ (1) | NZ510845A (sh) |
| PL (1) | PL346898A1 (sh) |
| PT (1) | PT1115704E (sh) |
| SI (1) | SI1115704T1 (sh) |
| SK (1) | SK4032001A3 (sh) |
| TR (1) | TR200100854T2 (sh) |
| WO (1) | WO2000018734A1 (sh) |
| YU (1) | YU21301A (sh) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904933D0 (en) | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
| AU2002341881B2 (en) * | 2001-09-27 | 2008-05-08 | Allergan, Inc. | 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
| US6797825B2 (en) | 2001-12-13 | 2004-09-28 | Abbott Laboratories | Protein kinase inhibitors |
| DK1490062T3 (da) | 2002-03-26 | 2008-04-28 | Boehringer Ingelheim Pharma | Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf |
| DE10233366A1 (de) * | 2002-07-23 | 2004-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
| PE20040701A1 (es) * | 2002-07-23 | 2004-11-30 | Boehringer Ingelheim Pharma | Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos |
| US7514468B2 (en) | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
| US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
| US20040204458A1 (en) | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
| DE10237423A1 (de) * | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| NZ538932A (en) * | 2002-08-29 | 2007-04-27 | Boehringer Ingelheim Pharma | 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease |
| US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
| JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
| US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| UY28526A1 (es) | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
| CA2541059C (en) * | 2003-10-03 | 2013-09-17 | Boehringer Ingelheim Pharmaceuticals, Inc. | Fluorescent probes for use in protein kinase inhibitor binding assay |
| US7897788B2 (en) | 2004-03-11 | 2011-03-01 | Actelion Pharmaceutical Ltd. | Indol-1-yl-acetic acid derivatives |
| US7795272B2 (en) | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| PE20061155A1 (es) * | 2004-12-24 | 2006-12-16 | Boehringer Ingelheim Int | Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| ATE433958T1 (de) | 2004-12-27 | 2009-07-15 | Boehringer Ingelheim Pharma | Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung |
| EP1877376A1 (de) | 2005-04-28 | 2008-01-16 | Boehringer Ingelheim International GmbH | Neue verbindungen zur behandlung von entzündlichen erkrankungen |
| AU2007329548A1 (en) | 2006-12-06 | 2008-06-12 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| BRPI0717688A2 (pt) * | 2006-12-11 | 2013-01-22 | Genentch Inc Empresa Americana | mÉtodos para tratar neoplasma e mÉtodos para tratar neoplasma de plasmàcitos |
| CN101273991B (zh) * | 2007-03-28 | 2010-05-26 | 广东同德药业有限公司 | 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用 |
| UY31506A1 (es) * | 2007-12-03 | 2009-08-03 | Derivados de indolinona y procedimiento para su preparacion | |
| US8304541B2 (en) * | 2007-12-03 | 2012-11-06 | Boehringer Ingelheim International Gmbh | Process for the manufacture of an indolinone derivative |
| CA2712388A1 (en) * | 2008-01-25 | 2009-07-30 | Boehringer Ingelheim International Gmbh | Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| ES2381257T3 (es) | 2008-06-06 | 2012-05-24 | Boehringer Ingelheim International Gmbh | Miméticos de glucocorticoides, métodos para su fabricación, composiciones farmacéuticas y usos de los mismos |
| KR20110039474A (ko) | 2008-07-29 | 2011-04-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 신규한 화합물 |
| WO2013137371A1 (ja) * | 2012-03-15 | 2013-09-19 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
| CN103664737A (zh) * | 2012-09-25 | 2014-03-26 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
| US11666888B2 (en) | 2018-02-05 | 2023-06-06 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
| CN114957084B (zh) * | 2022-01-21 | 2023-05-09 | 九江学院 | 一种吲哚酮类化合物及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501567D0 (en) * | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
-
1999
- 1999-09-22 CN CN99811297A patent/CN1319090A/zh active Pending
- 1999-09-22 IL IL14162299A patent/IL141622A0/xx unknown
- 1999-09-22 AU AU60863/99A patent/AU763361B2/en not_active Ceased
- 1999-09-22 PL PL99346898A patent/PL346898A1/xx not_active Application Discontinuation
- 1999-09-22 EA EA200100320A patent/EA200100320A1/ru unknown
- 1999-09-22 EP EP99947404A patent/EP1115704B1/de not_active Expired - Lifetime
- 1999-09-22 KR KR1020017003773A patent/KR20010085841A/ko not_active Application Discontinuation
- 1999-09-22 CA CA002342622A patent/CA2342622A1/en not_active Abandoned
- 1999-09-22 AT AT99947404T patent/ATE243195T1/de not_active IP Right Cessation
- 1999-09-22 NZ NZ510845A patent/NZ510845A/en unknown
- 1999-09-22 YU YU21301A patent/YU21301A/sh unknown
- 1999-09-22 EE EEP200100184A patent/EE200100184A/xx unknown
- 1999-09-22 TR TR2001/00854T patent/TR200100854T2/xx unknown
- 1999-09-22 DK DK99947404T patent/DK1115704T3/da active
- 1999-09-22 WO PCT/EP1999/007040 patent/WO2000018734A1/de not_active Application Discontinuation
- 1999-09-22 BR BR9914065-9A patent/BR9914065A/pt unknown
- 1999-09-22 ES ES99947404T patent/ES2196860T3/es not_active Expired - Lifetime
- 1999-09-22 ID IDW20010688A patent/ID27757A/id unknown
- 1999-09-22 DE DE59906030T patent/DE59906030D1/de not_active Expired - Fee Related
- 1999-09-22 SK SK403-2001A patent/SK4032001A3/sk unknown
- 1999-09-22 SI SI9930391T patent/SI1115704T1/xx unknown
- 1999-09-22 JP JP2000572194A patent/JP2002525356A/ja active Pending
- 1999-09-22 PT PT99947404T patent/PT1115704E/pt unknown
- 1999-09-22 HU HU0104973A patent/HUP0104973A3/hu unknown
-
2001
- 2001-03-09 BG BG105327A patent/BG105327A/xx active Pending
- 2001-03-21 HR HR20010216A patent/HRP20010216A2/hr not_active Application Discontinuation
- 2001-03-22 NO NO20011477A patent/NO20011477D0/no not_active Application Discontinuation
-
2003
- 2003-09-19 US US10/666,643 patent/US6855710B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| TR200100854T2 (tr) | 2001-12-21 |
| EP1115704A1 (de) | 2001-07-18 |
| EE200100184A (et) | 2002-08-15 |
| AU763361B2 (en) | 2003-07-17 |
| ATE243195T1 (de) | 2003-07-15 |
| CN1319090A (zh) | 2001-10-24 |
| KR20010085841A (ko) | 2001-09-07 |
| HUP0104973A3 (en) | 2002-06-28 |
| NO20011477L (no) | 2001-03-22 |
| AU6086399A (en) | 2000-04-17 |
| ID27757A (id) | 2001-04-26 |
| IL141622A0 (en) | 2002-03-10 |
| SK4032001A3 (en) | 2001-11-06 |
| EP1115704B1 (de) | 2003-06-18 |
| CA2342622A1 (en) | 2000-04-06 |
| HRP20010216A2 (en) | 2002-04-30 |
| BG105327A (en) | 2001-12-29 |
| PT1115704E (pt) | 2003-11-28 |
| PL346898A1 (en) | 2002-03-11 |
| BR9914065A (pt) | 2001-06-19 |
| EA200100320A1 (ru) | 2001-10-22 |
| JP2002525356A (ja) | 2002-08-13 |
| DK1115704T3 (da) | 2003-09-29 |
| HUP0104973A2 (hu) | 2002-04-29 |
| YU21301A (sh) | 2003-04-30 |
| NO20011477D0 (no) | 2001-03-22 |
| ES2196860T3 (es) | 2003-12-16 |
| US20040058978A1 (en) | 2004-03-25 |
| DE59906030D1 (de) | 2003-07-24 |
| WO2000018734A1 (de) | 2000-04-06 |
| NZ510845A (en) | 2003-10-31 |
| US6855710B2 (en) | 2005-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL141622A0 (en) | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes | |
| MY127956A (en) | Substituted indolines which inhibit receptor tyrosine kinases | |
| MY122357A (en) | Indolinones having kinase inhibitory activity | |
| YU73900A (sh) | Supstituisani indolinoni, njihovo pripremanje i njihova primena kao lekova | |
| WO2002024700A3 (en) | SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES | |
| HK1047098A1 (en) | Tri-aryl acid derivatives as ppar receptor ligands. | |
| AU5165393A (en) | Substituted benzylaminoquinuclidines as substance p antagonists | |
| YU13200A (sh) | Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja | |
| WO2004026829A3 (de) | Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren | |
| WO2001027080A3 (de) | In 5-stellung substituierte indolinone und ihre verwendung als kinase und cyclin-cdk-komplexe inhibitoren | |
| AU2713397A (en) | Process for preparation of pyrimidine derivatives | |
| RS20050047A (en) | Indoline derivatives substituted in position 6,production and use thereof as medicaments | |
| HK1052928A1 (en) | Process for preparing azacycloalkanoylaminothiazoles | |
| NZ508852A (en) | 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use in treating CNS and circulation disorders | |
| AU2003273675A1 (en) | Protein tyrosine kinase inhibitors | |
| GB9806409D0 (en) | Processes for preparing intermediates | |
| HUP0000854A2 (hu) | 4-[6-Fluor-(1H)-indol-3-il]-1,2,3,6-tetrahidropiridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás mindezek előállítására | |
| YU3701A (sh) | Supstituisani fenilamidini sa antitrombskim dejstvom | |
| UY26308A1 (es) | Nuevas indolinonas sustituidas, su preparación y su empleo como medicamentos | |
| MY120806A (en) | Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives. | |
| AU8553498A (en) | Process for the preparation of imidazolones | |
| TH57154B (th) | ซับสทิทิวเทด อินโดลิโนน ชนิดใหม่, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้เป็นสารผสมทางเภสัช |